BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37302412)

  • 21. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome.
    Steinberg Weiss M; Roe AH; Allison KC; Dodson WC; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Sarwer DB; Coutifaris C; Legro RS; Dokras A
    Fertil Steril; 2021 Feb; 115(2):474-482. PubMed ID: 33059886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.
    Noroozzadeh M; Tehrani FR; Mobarakabadi SS; Farahmand M; Dovom MR
    Int J Impot Res; 2017 Jan; 29(1):1-6. PubMed ID: 27654035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of health-related quality of life in different polycystic ovary syndrome phenotypes: A cross-sectional study.
    Li X; Cui T; Song X; Tian W; Lin Y; Zhang H
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():189-194. PubMed ID: 35220174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiographic evaluation of diastolic functions in patients with polycystic ovary syndrome: A comperative study of diastolic functions in sub-phenotypes of polycystic ovary syndrome.
    Yildirim E; Karabulut O; Yuksel UC; Celik M; Bugan B; Gokoglan Y; Ulubay M; Gungor M; Koklu M
    Cardiol J; 2017; 24(4):364-373. PubMed ID: 28353313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Hormonal Profile, Weight, and Body Image on Sexual Function in Women with Polycystic Ovary Syndrome.
    Daescu AC; Dehelean L; Navolan DB; Gaitoane AI; Daescu A; Stoian D
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is polycystic ovary syndrome associated with risk of female sexual dysfunction? A systematic review and meta-analysis.
    Zhao S; Wang J; Xie Q; Luo L; Zhu Z; Liu Y; Luo J; Zhao Z
    Reprod Biomed Online; 2019 Jun; 38(6):979-989. PubMed ID: 30926178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Pastoor H; Mousa A; Bolt H; Bramer W; Burgert TS; Dokras A; Tay CT; Teede HJ; Laven J
    Hum Reprod Update; 2024 May; 30(3):323-340. PubMed ID: 38237144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total and bioavailable 25-hydroxyvitamin D is not associated with improved sexual dysfunction following vitamin D supplementation in women with polycystic ovarian syndrome: a pilot study.
    Eickman K; Maxwell R; McGinnis LK; Stanczyk F; Legro R; Lindheim SR
    J Sex Med; 2024 Feb; 21(3):240-247. PubMed ID: 38303661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary Syndrome.
    Lara LA; Ramos FK; Kogure GS; Costa RS; Silva de Sá MF; Ferriani RA; dos Reis RM
    J Sex Med; 2015 Jul; 12(7):1584-90. PubMed ID: 25982537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes.
    Kabakchieva P; Gateva A; Hristova J; Georgiev T; Kamenov Z
    Cannabis Cannabinoid Res; 2023 Aug; 8(4):634-641. PubMed ID: 35235418
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
    Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R
    Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and anthropometric characteristics of Rotterdam criteria-based phenotypic forms of Polycystic ovaries syndrome in Ukraine.
    Tatarchuk T; Pedachenko N; Kosei N; Malysheva I; Snizhko T; Kozub T; Zolotarevska O; Kosianenko S; Tutchenko T
    Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():104-110. PubMed ID: 38354601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual function in women with polycystic ovary syndrome.
    Stovall DW; Scriver JL; Clayton AH; Williams CD; Pastore LM
    J Sex Med; 2012 Jan; 9(1):224-30. PubMed ID: 22082203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype.
    Barbagallo F; Pedrielli G; Bosoni D; Tiranini L; Cucinella L; Calogero AE; Facchinetti F; Nappi RE
    J Endocrinol Invest; 2023 Aug; 46(8):1623-1632. PubMed ID: 36735200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.